Study of EQU-001 for Uncontrolled Focal Onset Seizures

PHASE2TerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 27, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions
Focal Onset Seizures
Interventions
DRUG

EQU-001

20 mg pills of EQU-001

OTHER

Matching Placebo

20 mg matching placebo pills

Trial Locations (13)

10016

NYU Langone Health, New York

19107

Comprehensive Epilepsy Center at Thomas Jefferson University, Philadelphia

20817

Mid-Atlantic Epilepsy and Sleep Center, Bethesda

22903

University of Virginia, Charlottesville

73112

Sooner Clinical Research, Inc., Oklahoma City

77429

Northwest Houston Neurology, Cypress

83702

Consultants in Epilepsy and Neurology, PLLC, Boise

3109601

Ramban Health Care Campus, Haifa

4941492

Rabin Medical Center, Petah Tikva

5262000

Chaim Sheba Medical center, Ramat Gan

6423906

Tel Aviv Sourasky Medical Center, Tel Aviv

9112001

Hadassah Medical Center, Jerusalem

07039

Institute of Neurology and Neurosurgery at Saint Barnabas, Livingston

All Listed Sponsors
lead

Equilibre Biopharmaceuticals B.V.

INDUSTRY